Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Bayer AG

02 4Novo Nordisk

03 6Takeda Pharmaceutical

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

ANTIHEMOPHILIC FACTOR (RECOMBINANT)

Brand Name : KOVALTRY

Dosage Form : KIT

Dosage Strength : 250UNIT/VIAL

Packaging : 2.5ML

Approval Date :

Application Number : 2451441

Regulatory Info : Schedule D

Registration Country : Canada

blank

02

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

ANTIHEMOPHILIC FACTOR (RECOMBINANT)

Brand Name : KOVALTRY

Dosage Form : KIT

Dosage Strength : 500UNIT/VIAL

Packaging : 2.5ML

Approval Date :

Application Number : 2451468

Regulatory Info : Schedule D

Registration Country : Canada

blank

03

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

ANTIHEMOPHILIC FACTOR (RECOMBINANT)

Brand Name : KOVALTRY

Dosage Form : KIT

Dosage Strength : 1000UNIT/VIAL

Packaging : 2.5ML

Approval Date :

Application Number : 2451476

Regulatory Info : Schedule D

Registration Country : Canada

blank

04

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

ANTIHEMOPHILIC FACTOR (RECOMBINANT)

Brand Name : KOVALTRY

Dosage Form : KIT

Dosage Strength : 2000UNIT/VIAL

Packaging : 5ML

Approval Date :

Application Number : 2451484

Regulatory Info : Schedule D

Registration Country : Canada

blank

05

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

ANTIHEMOPHILIC FACTOR (RECOMBINANT)

Brand Name : KOVALTRY

Dosage Form : KIT

Dosage Strength : 3000UNIT/VIAL

Packaging : 5ML

Approval Date :

Application Number : 2451492

Regulatory Info : Schedule D

Registration Country : Canada

blank

06

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Antihemophilic factor recombinant

Brand Name : JIVI

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 500UNIT/VIAL

Packaging : 500

Approval Date :

Application Number : 2481766

Regulatory Info : Schedule D

Registration Country : Canada

blank

07

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Antihemophilic factor recombinant

Brand Name : JIVI

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 1000UNIT/VIAL

Packaging :

Approval Date :

Application Number : 2481774

Regulatory Info : Schedule D

Registration Country : Canada

blank

08

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Antihemophilic factor recombinant

Brand Name : JIVI

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 3000UNIT/VIAL

Packaging :

Approval Date :

Application Number : 2481790

Regulatory Info : Schedule D

Registration Country : Canada

blank

09

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Antihemophilic factor recombinant

Brand Name : ESPEROCT

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 500UNIT/VIAL

Packaging :

Approval Date :

Application Number : 2490064

Regulatory Info : Schedule D

Registration Country : Canada

blank

10

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Antihemophilic factor recombinant

Brand Name : ESPEROCT

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 1000UNIT/VIAL

Packaging :

Approval Date :

Application Number : 2490072

Regulatory Info : Schedule D

Registration Country : Canada

blank

11

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Antihemophilic factor recombinant

Brand Name : ESPEROCT

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 2000UNIT/VIAL

Packaging :

Approval Date :

Application Number : 2490099

Regulatory Info : Schedule D

Registration Country : Canada

blank

12

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Antihemophilic factor recombinant

Brand Name : ESPEROCT

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 3000UNIT/VIAL

Packaging :

Approval Date :

Application Number : 2490102

Regulatory Info : Schedule D

Registration Country : Canada

blank

13

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Antihemophilic factor recombinant

Brand Name : ADYNOVATE

Dosage Form : KIT

Dosage Strength : 250UNIT/VIAL

Packaging :

Approval Date :

Application Number : 2498537

Regulatory Info : Schedule D

Registration Country : Canada

blank

14

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Antihemophilic factor recombinant

Brand Name : ADYNOVATE

Dosage Form : KIT

Dosage Strength : 500UNIT/VIAL

Packaging :

Approval Date :

Application Number : 2498545

Regulatory Info : Schedule D

Registration Country : Canada

blank

15

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Antihemophilic factor recombinant

Brand Name : ADYNOVATE

Dosage Form : KIT

Dosage Strength : 1000UNIT/VIAL

Packaging :

Approval Date :

Application Number : 2498588

Regulatory Info : Schedule D

Registration Country : Canada

blank

16

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Antihemophilic factor recombinant

Brand Name : ADYNOVATE

Dosage Form : KIT

Dosage Strength : 3000UNIT/VIAL

Packaging :

Approval Date :

Application Number : 2498626

Regulatory Info : Schedule D

Registration Country : Canada

blank

17

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Antihemophilic factor recombinant

Brand Name : ADYNOVATE

Dosage Form : KIT

Dosage Strength : 2000UNIT/VIAL

Packaging : 5ML

Approval Date :

Application Number : 2459078

Regulatory Info : Schedule D

Registration Country : Canada

blank

18

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Antihemophilic factor recombinant

Brand Name : OBIZUR

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 500UNIT/ML

Packaging : 1ML RECONST. IN 3ML VIAL

Approval Date :

Application Number : 2447401

Regulatory Info : Schedule D

Registration Country : Canada

blank